MT
Meena Tummuru
About Meena Tummuru
Data last updated:
Meena Tummuru is an Individual Subscriber at American Institute For Cellular Oncology Private Limited (since 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 American Institute For Cellular Oncology Private Limited U46497TS2026PTC219384 | Individual Subscriber | 14 Jul 2026 | 2026 | Active |
Board colleagues of Meena Tummuru
| Name | DIN | Company | Designation |
|---|---|---|---|
| Murali Krishna Reddy Tummuru | 02469013 | American Institute For Cellular Oncology Private Limited | Director |
| Puneeth Babu Anne | 09351752 | American Institute For Cellular Oncology Private Limited | Individual Subscriber |
| Rajesh Bollam | 11010790 | American Institute For Cellular Oncology Private Limited | Individual Subscriber |
| Rajesh Reddy Tummuru | 05346342 | American Institute For Cellular Oncology Private Limited | Director |
| Usha Rani Kurre | 08158270 | American Institute For Cellular Oncology Private Limited | Individual Subscriber |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Meena Tummuru
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meena Tummuru
Meena Tummuru currently holds 1 directorship: American Institute For Cellular Oncology Private Limited (Individual Subscriber, since 14 Jul 2026).
Meena Tummuru was first appointed on 14 Jul 2026 as Individual Subscriber at American Institute For Cellular Oncology Private Limited.
The current boards of Meena Tummuru's companies include Murali Krishna Reddy Tummuru (American Institute For Cellular Oncology Private Limited), Puneeth Babu Anne (American Institute For Cellular Oncology Private Limited), Rajesh Bollam (American Institute For Cellular Oncology Private Limited), Rajesh Reddy Tummuru (American Institute For Cellular Oncology Private Limited), Usha Rani Kurre (American Institute For Cellular Oncology Private Limited).